Fibrosis Myocardial
6
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease
Atrial Fibrillation Driver Study
Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
Effects of Interval Training Effects on Cardiac Fibrosis
Cardiovascular Magnetic Resonance GUIDEd Insertion of Implantable Cardiac Defibrillator in Dilated CardioMyopathy